Drug Profile
Research programme: diabetes insulin-device combinations - Medtronic/Sanofi
Latest Information Update: 17 Jun 2014
Price :
$50
*
At a glance
- Originator Medtronic; Sanofi
- Class Insulins; Pancreatic hormones
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Phase Unknown Diabetes mellitus
Most Recent Events
- 14 Jun 2014 Investigation in Diabetes mellitus in Europe (SC)
- 14 Jun 2014 Investigation in Diabetes mellitus in USA (SC)